US 11,859,244 B2
Amplification oligonucleotides
Ryan Shultzaberger, San Diego, CA (US); Allen Lipson, San Diego, CA (US); and Daan Witters, San Diego, CA (US)
Assigned to Singular Genomics Systems, Inc., San Diego, CA (US)
Filed by Singular Genomics Systems, Inc, San Diego, CA (US)
Filed on Mar. 17, 2023, as Appl. No. 18/185,786.
Application 18/185,786 is a continuation of application No. PCT/US2022/075843, filed on Sep. 1, 2022.
Claims priority of provisional application 63/331,225, filed on Apr. 14, 2022.
Claims priority of provisional application 63/245,414, filed on Sep. 17, 2021.
Claims priority of provisional application 63/240,671, filed on Sep. 3, 2021.
Prior Publication US 2023/0287493 A1, Sep. 14, 2023
Int. Cl. C12Q 1/6874 (2018.01); C12Q 1/6876 (2018.01); C12Q 1/6855 (2018.01)
CPC C12Q 1/6855 (2013.01) [C12Q 1/6874 (2013.01); C12Q 1/6876 (2013.01)] 21 Claims
 
1. A kit comprising
a first oligonucleotide comprising a first sequencing primer sequence and a second sequencing primer binding sequence;
a second oligonucleotide comprising from 5′ to 3′, a first platform primer sequence and a sequence complementary to the first sequencing primer sequence;
a third oligonucleotide comprising from 5′ to 3′, a second platform primer sequence and a sequence complementary to the second sequencing primer binding sequence;
wherein said first platform primer sequence comprises SEQ ID NO:92; and
said second platform primer sequence comprises SEQ ID NO:89.